Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells

Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics

(2022) Ilene Le et al.   Vaccines

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

(2021) Yusuf Dölen et al.   Frontiers in Immunology

Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients

(2021) Takeshi Ishikawa et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial

(2021) Staffan Holmberg-Thydén et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines

(2021) Alexander J. Stephens et al.   Frontiers in Immunology

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide

(2021) Eugene Shenderov et al.   Journal for ImmunoTherapy of Cancer

Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma

(2020) Carole Grasso et al.   Immunotherapy

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

(2020) Afsheen Raza et al.   Journal of Translational Medicine

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

(2020) Ugur Sahin et al.   NATURE

Application of Bacteriophages in Nanotechnology

(2020) Jan Paczesny et al.   Nanomaterials

Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery

(2020) Alejandro González-Mora et al.   Vaccines

Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases

(2020) Nicolás M. S. Gálvez et al.   CLINICAL MICROBIOLOGY REVIEWS

An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells

(2019) Luciana D’Apice et al.   JOURNAL OF IMMUNOTHERAPY

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

(2019) Luigi Aurisicchio et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials

(2019) Yingting Zhang et al.   Frontiers in Immunology

The development of inovirus-associated vector vaccines using phage-display technologies

(2019) Zachariah Stern et al.   Expert Review of Vaccines

Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies

(2019) Rossella Sartorius et al.   Pharmaceutics

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

(2019) Anna Pavlick et al.   Cancer Immunology Research

Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control

(2018) Yuki Kinjo et al.   Frontiers in Immunology

Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response

(2018) Rossella Sartorius et al.   Frontiers in Immunology

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy

(2017) Melissa Bedard et al.   Frontiers in Immunology

Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model

(2017) Feng Chen et al.   Scientific Reports

Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins

(2017) M. Speir et al.   Scientific Reports

The present status and future prospects of peptide-based cancer vaccines

(2016) Masatoshi Hirayama et al.   INTERNATIONAL IMMUNOLOGY

Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1

(2016) Sabrina Jutz et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response

(2015) R. Sartorius et al.   EMBO Molecular Medicine

NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity

(2015) Regan J. Anderson et al.   Chemical Science

Phage therapy gets revitalized

(2014) Sara Reardon   NATURE

A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy

(2014) Regan J Anderson et al.   Nature Chemical Biology

Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies

(2013) Girja S. Shukla et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation

(2012) Daniëlle Horst et al.   Viruses-Basel

Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants

(2011) Rossella Sartorius et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling

(2010) Shuhei Hashiguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Translating Tumor Antigens into Cancer Vaccines

(2010) Luigi Buonaguro et al.   Clinical and Vaccine Immunology